Amgen K.K
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.
See below for the Latest Amgen K.K News, Analysis, Profit Results, Share Price Information, and Commentary.
NSG biolabs, Amgen partner to leverage biotech ecosystem
NSG biolabs, Amgen partner to leverage biotech ecosystem
It will begin a program to help biotech startups innovate.
Commentary
Where does value creation really happen?
Managing the cost of diverging standards: Why Singapore matters
Singapore’s AI ambition has an intelligence problem
Singapore is deploying AI at speed – and security risks are catching up
Precious metal boom is a stress test for Singapore’s gold ambitions
Singapore’s global dispute fault lines
‘Tokenmaxxing’ – The wrong AI race to run in Singapore
To outsmart modern fraud, we must first know the enemy
Why Singapore SMEs cannot wait for quantum cyber risk to arrive before securing data